Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Expert Opin Ther Pat. 2019 Dec 19;30(1):39–55. doi: 10.1080/13543776.2020.1705783

Figure 5.

Figure 5.

The chemical structures of 2-oxopyridine-based inhibitors of FXIa (916) filed by Bayer Pharma, Germany. Provided are the FXIa and PK IC50 values (nM).